Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BOrient Pharma Co., Ltd. 〉Miglitol Tablets

Miglitol Tablets

Miglitol Tablets

Orient Pharma's Miglitol Tablets is First-to-Approval ANDA in US.

Request for Collaboration
Overview
  • Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to break down complex carbohydrates into glucose.
  • Miglitol can be used alone or in combination with other anti-diabetic agents.
  • Orient Pharma's Miglitol Tablets was launched in the United States in 2016.
  • The out-licensing and distribution in other countries is open for collaboration.
Features
Miglitol produces reductions in HbA1c, as well as a significant reduction in postprandial plasma, mean fasting and postprandial plasma glucose levels and in mean postprandial insulin levels.
Specifications
  1. Miglitol Tablets 25mg, 100s in bottle
  2. Miglitol Tablets 50mg, 100s in bottle 
  3. Miglitol Tablets 100mg,100s in bottle
Application
Type 2 diabetes
Collaboration Options
Distribution, oepn for global market
People who like this also like
  • PG2 Lyo.Injection 500mgPG2 Lyo.Injection 500mg
  • Bone Type Implant SystemBone Type Implant System
  • Spear Locking PlateSpear Locking Plate
  • Inpheno Tablets 100 mg(Sapropterin Dihydrochloride)Inpheno Tablets 100 mg(Sapropterin Dihydrochloride)
  • Active Pharmaceutical Ingredients (APIs)Active Pharmaceutical Ingredients (APIs)
  • Miko DripMiko Drip
  • Hereditary Risk EvaluationHereditary Risk Evaluation
  • Facial Dermal ImplantFacial Dermal Implant
  • MyGene Cancer ScreeningMyGene Cancer Screening
  • Anscare Healus Foam / Healus Foam ExtraAnscare Healus Foam / Healus Foam Extra